A randomized multicentric phase III ongoing study of adjuvant fotemustine versus observation in high risk uveal melanoma patients (FOTEADJ)
Acta Ophthalmologica, 08/16/2012
Clinical Article
Piperno–neumann S – June 2009–Jan 2012:70 patients were included in 4 participating centres, extension to other countries is underway.



